logo

Organometallic chemistry: synthesis and applications of cyclometallated compounds
Research lines and collaborations (in blue active lines)

  • Intramolecular C-X activation in molecular compounds of Mn(I) (X = H or Cl), Ru(II) (X = H), Ni(0) (X = F, Cl or Br), Pd(0) (X = Cl), Pd(II) (X = H or O), Pt(0) (X = H, F, Cl or Br) and Pt(II) (X = H, F, Cl, Br or I): Applications in organometallic and organic synthesis. Developed in collaboration with Drs J. Sales, G. Muller, R. M. Ceder, C. López, A. Grabulosa, D. Sainz (Inorganic Chemistry Section UB), M. Gómez (Université Tolouse-3, Paul Sabatier), C. Anderson (Bard College), and A. González (Department of Organic Chemistry, Pharmacy Faculty UB).
  • Crystal structures of cyclometallated compounds and related compounds. Developed in collaboration with Drs X. Solans (Crystallography Department UB), M. Font-Bardia (Scientific-Technical Services UB), C. Puerta, P. Valerga (Cádiz University), L. Barrios (Inorganic Chemistry Section UB), and  M. C. Puigjaner (Scientific-Technical Services UB).
  • Reactions of cyclometallation at Pd(II) and Pt(II) centres and  of oxidative addition at Pt(II) centres: Reaction kinetics and activation parameters. Developed in collaboration with Dr M. Martínez (Inorganic Chemistry Section UB).
  • Optical resolution of chiral phosphines by optically active cyclometallated palladium(II) compounds. Developed in collaboration with Drs G. Muller, D. Sainz and M. Rocamora (Inorganic Chemistry Section UB).
  • Electrochemistry of Pt(II) and Pt(IV) cyclometallated compounds. Developed in collaboration with Drs A. Klein (Institut für Anorganische Chemie der Universität Stuttgart) and C. López (Inorganic Chemistry Section UB).
  • Computational studies: Optimization of: i) the geometry of Pd(II), Pt(II) and Pt(IV) molecular compounds, and ii) cyclometallation reactions transition states. Developed in collaboration with Drs R. Bosque, G. Aullón and J. Jover (Inorganic Chemistry Section UB).
  • Catalytic functionalization of C-H bonds by directing groups and Pd(0) or Pd(II) catalysts. Developed in collaboration with Drs J. García, X. Ariza, E. Nicolás and J. Farrŕs (Organic Chemistry Section UB).
  • Cyclometallated Pd(II), Pt(II) and Pt(IV) compounds: Cytotoxicity. Developed in collaboration with Drs M. Cascante (Biochemistry and Molecular Biomedicine Department UB), R. Messeguer (LEITAT) and J. Quirante (Pharmacology, Toxicology and Therapeutic Chemistry Department UB). Cell cycle arrest, apoptosis and ROS (reactive oxygen species). Developed in collaboration with Drs M. Cascante (Biochemistry and Molecular Biomedicine Department UB) and J. Quirante (Pharmacology, Toxicology and Therapeutic Chemistry Department UB). Interaction with DNA and enzymes. Developed in collaboration with Drs L. Baldomŕ and J. Badia (Biochemistry and Physiology Department UB) and J. Quirante (Pharmacology, Toxicology and Therapeutic Chemistry Department UB).
  • Luminescent Pt(II) and Pt(IV) cyclometallated compounds. Developed in collaboration with Dr L. Rodríguez (Inorganic Chemistry Section UB).
  • Pd(II) cyclometallated compounds antibacterial and antioxidant activity in vitro. Developed in collaboration with Dr K. Khosa (GC University Faisalabad).
  • Application of imine cyclometallated Ru(II) and Pd(II) compounds in catalysis. Developed in collaboration with Drs A. Grabulosa and D. Sainz (Inorganic Chemistry Section UB).
drx4